References and Further Reading
Abate, F., Ambrosio, M. R., Mundo, L., Laginestra, M. A., Fuligni, F., Rossi, M., Zairis, S., Gazaneo, S., De Falco, G., Lazzi, S., Bellan, C., Rocca, B. J., Amato, T., Marasco, E., Etebari, M., Ogwang, M., Calbi, V., Ndede, I., Patel, K., Chumba, D., Piccaluga, P. P., Pileri, S., Leoncini, L., & Rabadan, R. (2015). Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathogens, 11, e1005158.
Amato, T., Abate, F., Piccaluga, P., Iacono, M., Fallerini, C., Renieri, A., De Falco, G., Ambrosio, M. R., Mourmouras, V., Ogwang, M., Calbi, V., Rabadan, R., Hummel, M., Pileri, S., Leoncini, L., & Bellan, C. (2016). Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic Burkitt lymphoma suggests antigen drive activation of BCR as opposed to sporadic Burkitt lymphoma. American Journal of Clinical Pathology, 145, 116–127.
Ambrosio, M. R., Piccaluga, P. P., Ponzoni, M., Rocca, B. J., Malagnino, V., Onorati, M., De Falco, G., Calbi, V., Ogwang, M., Naresh, K. N., Pileri, S. A., Doglioni, C., Leoncini, L., & Lazzi, S. (2012). The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: Adipophilin. PLoS One, 7(8), e44315.
Ambrosio, M. R., Navari, M., Di Lisio, L., Leon, E. A., Onnis, A., Gazaneo, S., Mundo, L., Ulivieri, C., Gomez, G., Lazzi, S., Piris, M. A., Leoncini, L., & De Falco, G. (2014). The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agent and Cancer, 9, 12.
Ambrosio, M. R., Lo Bello, G., Amato, T., Lazzi, S., Piccaluga, P. P., Leoncini, L., & Bellan, C. (2016). The cell of origin of Burkitt lymphoma: Germinal Centre or not germinal Centre? Histopathology, 69(5), 885–886.
Ambrosio, M. R., Lazzi, S., Bello, G. L., Santi, R., Del Porro, L., de Santi, M. M., Guazzo, R., Mundo, L., Rigacci, L., Kovalchuck, S., Onyango, N., Fabbri, A., Cencini, E., Zinzani, P. L., Zaja, F., Angrilli, F., Stelitano, C., Cabras, M. G., Spataro, G., Bob, R., Menter, T., Granai, M., Cevenini, G., Naresh, K. N., Stein, H., Sabattini, E., & Leoncini, L. (2018). MYC protein expression scoring and its impact on the prog-nosis of aggressive B-cell lymphoma patients. Haemathologica. https://doi.org/10.3324/haematol.2018.195958.
Disanto, M. G., Ambrosio, M. R., Rocca, B. J., Ibrahim, H. A., Leoncini, L., & Naresh, K. N. (2016). Optimal minimal panels of immunohistochemistry for diagnosis of B-cell lymphoma for application in countries with limited resources and for triaging cases before referral to specialist centers. American Journal of Clinical Pathology, 145(5), 687–695.
Delabie, J., Smeland, E. B., Ogwang, M. D., Reynolds, S. J., Fisher, R. I., Braziel, R. M., Tubbs, R. R., Cook, J. R., Weisenburger, D. D., Chan, W. C., Pittaluga, S., Wilson, W., Waldmann, T. A., Rowe, M., Mbulaiteye, S. M., Rickinson, A. B., & Staudt, L. M. (2012). Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature, 490(7418), 116–120.
Lenze, D., Leoncini, L., Hummel, M., Volinia, S., Liu, C. G., Amato, T., De Falco, G., Githanga, J., Horn, H., Nyagol, J., Ott, G., Palatini, J., Pfreundschuh, M., Rogena, E., Rosenwald, A., Siebert, R., Croce, C. M., & Stein, H. (2011). The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia, 25, 1869–1876.
Love, C., Sun, Z., Jima, D., Li, G., Zhang, J., Miles, R., Richards, K. L., Dunphy, C. H., Choi, W. W., Srivastava, G., Lugar, P. L., Rizzieri, D. A., Lagoo, A. S., Bernal-Mizrachi, L., Mann, K. P., Flowers, C. R., Naresh, K. N., Evens, A. M., Chadburn, A., Gordon, L. I., Czader, M. B., Gill, J. I., Hsi, E. D., Greenough, A., Moffitt, A. B., McKinney, M., Banerjee, A., Grubor, V., Levy, S., Dunson, D. B., & Dave, S. S. (2012). The genetic landscape of mutations in Burkitt lymphoma. Nature Genetics, 44, 1321–1325.
Magrath, I. (2012). Epidemiology: Clues to the pathogenesis of Burkitt lymphoma. British Journal of Haematology, 156, 744–756.
Mundo, L., Ambrosio, M. R., Picciolini, M., Lo Bello, G., Gazaneo, S., Del Porro, L., Lazzi, S., Navari, M., Onyango, N., Granai, M., Bellan, C., De Falco, G., Gibellini, D., Piccaluga, P. P., & Leoncini, L. (2017). Frontiers in Microbiology, 8, 229.
Naresh, K. N., Ibrahim, H. A., Lazzi, S., Rince, P., Onorati, M., Ambrosio, M. R., Bilhou-Nabera, C., Amen, F., Reid, A., Mawanda, M., Calbi, V., Ogwang, M., Rogena, E., Byakika, B., Sayed, S., Moshi, E., Mwakigonja, A., Raphael, M., Magrath, I., & Leoncini, L. (2011). Diagnosis of Burkitt lymphoma using an algorithmic approach – Applicable in both resource-poor and resource-rich countries. British Journal of Haematology, 154, 770–776.
Richter, J., Schlesner, M., Hoffmann, S., Kreuz, M., Leich, E., Burkhardt, B., Rosolowski, M., Ammerpohl, O., Wagener, R., Bernhart, S. H., Lenze, D., Szczepanowski, M., Paulsen, M., Lipinski, S., Russell, R. B., Adam-Klages, S., Apic, G., Claviez, A., Hasenclever, D., Hovestadt, V., Hornig, N., Korbel, J. O., Kube, D., Langenberger, D., Lawerenz, C., Lisfeld, J., Meyer, K., Picelli, S., Pischimarov, J., Radlwimmer, B., Rausch, T., Rohde, M., Schilhabel, M., Scholtysik, R., Spang, R., Trautmann, H., Zenz, T., Borkhardt, A., Drexler, H. G., Möller, P., MacLeod, R. A., Pott, C., Schreiber, S., Trümper, L., Loeffler, M., Stadler, P. F., Lichter, P., Eils, R., Küppers, R., Hummel, M., Klapper, W., Rosenstiel, P., Rosenwald, A., Brors, B., & Siebert, R. (2012). Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nature Genetics, 44, 1316–1320.
Swerdlow, S. H., Campo, E., Harris, N. L., et al. (2017). WHO classification of tumours of the edition. Lyon: IARC Press.
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., Liu, X., Powell, J., Yang, Y., Xu, W., Zhao, H., Kohlhammer, H., Rosenwald, A., Kluin, P., Müller-Hermelink, H. K., Ott, G., Gascoyne, R. D., Connors, J. M., Rimsza, L. M., Campo, E., Jaffe, E. S., Delabie, J., Smeland, E. B., Ogwang, M. D., Reynolds, S. J., Fisher, R. I., Braziel, R. M., Tubbs, R. R., Cook, J. R., Weisenburger, D. D., Chan, W. C., Pittaluga, S., Wilson, W., Waldmann, T. A., Rowe, M., Mbulaiteye, S. M., Rickinson, A. B., & Staudt, L. M. (2012). Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature, 490(7418), 116–120.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this entry
Cite this entry
Ambrosio, M.R., Rocca, B.J., Leoncini, L. (2018). Burkitt Lymphoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_3837-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_3837-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine